Alumis Inc. (ALMS) vs Beta Bionics, Inc. (BBNX)
A side-by-side comparison of Alumis Inc. and Beta Bionics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMS
Alumis Inc.
$6.84HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
BBNX
Beta Bionics, Inc.
$18.95HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALMS vs BBNX
growth of $100 · dividends reinvested · last 2yALMS +1.8% (+0.9%/yr)BBNX -19.8% (-10.4%/yr)ALMS compounded faster over this window
ALMS BBNX
ALMS vs BBNX: by the numbers
- •BBNX is the larger company ($853M vs $844M market cap).
- •Both run net losses; BBNX's is the smaller (-61.32% vs -5933.45% net margin).
Metrics side by side
Valuation
| Metric | ALMS | BBNX |
|---|---|---|
| P/S ratio | 114.12 | 7.16 |
| P/B ratio | 1.87 | 3.33 |
Profitability
| Metric | ALMS | BBNX |
|---|---|---|
| Gross margin | 88.23% | 58.31% |
| Operating margin | -1776.32% | -69.75% |
| Net margin | -5933.45% | -61.32% |
| ROE | -97.08% | -28.46% |
| ROIC | -94.76% | -31.17% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.